Acumen Fund Announces Two Investments Providing Advanced Eye Care Services in India ... (d services to millions of rural and urba...)

(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th

(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud

(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be

(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the

(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel

Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2 Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2 Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2 Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3 Health News:Potential new 'twist' in breast cancer detection 2 Health News:Potential new 'twist' in breast cancer detection 3

[0] Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana [0] BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use [0] The Leapfrog Group Releases Its 2009 Top Hospitals List [0] News brief -- childhood cancer survivor study report: Late recurrence is a risk for some cancers [0] Potential new 'twist' in breast cancer detection

...isk of developing liver cancer and more than twice...researchers based on findings of a recent study. ...agnosed with 12 different types of cancer to 509 h...pendent of other factors like participants' body m...

...researchers suggest that the risk factors for hear...nearly 2,000 teens studied, about two-thirds had a... as 10 percent had a cluster of risk factors known... heart disease and diabetes. For the purpose of th...

...tic hypotension have problems with sinking blood p.../ Current treatments help increase blood pressure ...r when lying down, increasing the risk for stroke....ic hypotension especially common in those over age...

...ncer death worldwide, accounting for more than 1.3...rd to detect in early and treatable stages, most c...tudies have shown CT scans can identify the diseas...ecent study, researchers used PET scans to confirm...

...benefit from early magnetic resonance imaging, acc...o neuroscientists in Canada MRI technology could d...ients. They say they found that trauma-induced spi...ly certain the procedure will benefit the patient,...

... in soy could be good for the hearts and bones of ...parate studies suggest the natural plant estrogens...the body's own estrogen, therefore making soy espe...tter cholesterol levels compared to monkeys who at...

Other Medicine News:Health News:New Drug Effective for Low Blood Pressure 2

Risk for Cancer Increases In Diabetics Weight Of Child A Predictor Of Heart Disease Later In Life New Drug Effective for Low Blood Pressure Detecting Lung Cancer In Its Initial Stages Effective Diagnosis Of Spinal Cord Injuries The Benefits Of Soy

(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present

(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d

[0] Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference [0] PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop [0] PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop

...xpansion of Company,s Phase 3 Study for Wet AMD af...ata, FREMONT, Calif., April 17 NeoVista, Inc. an...ration (FDA) has granted the,company,s request to ...votal Phase 3 trial from 10 to 30 in the United St...ndary to AMD Treated with BEta RadiatioN,Epiretina...

...il 17 Innocoll, Inc., a privately-held,biopharmac...e planned phase,2 clinical trials sponsored by its...d, to investigate CollaRx(R) GENTAMICIN TOPICAL fo...c foot ulcers, has commenced,dosing. CollaRx GENTA...ble,Gentamicin-Collagen Sponge formulated and manu...

Other Medicine Technology:FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 2 FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 3 Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 2 Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 3 Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 4

FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S.Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers

...s for performing erythrocyte sedimentation rate (E...on of the Ves-matic System DIESSE brings to the cl...ting system which addresses and resolves every tec...ESR techique.,By means of a fully automated analyz...

...ntation rate analysers, which are especially user-...well-established advantages of the existing analys...ch guarantee time-saving standardised analysis of ...ness is an essential aspect of daily recurrent rou...

Mix-Rate

Medicine Products:

Ves-matic 10 Ves-matic 20 VACUETTE SRS 100/II Mix-Rate

Acumen Fund Announces Two Investments Providing Advanced Eye Care Services in India ...(d services to millions of rural and urba...),Health